Myriad Genetics Appoints Of Scott Leffler As CFO Effective Jan. 29, 2024; Succeeds Bryan Riggsbee; Riggsbee Will Continue As Strategic Advisor Through March 31, 2024, To Ensure A Smooth Transition
Portfolio Pulse from Benzinga Newsdesk
Myriad Genetics has announced the appointment of Scott Leffler as CFO, effective January 29, 2024. He will succeed Bryan Riggsbee, who will remain as a strategic advisor until March 31, 2024, to ensure a smooth transition.
December 21, 2023 | 1:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Scott Leffler's appointment as CFO of Myriad Genetics could bring fresh financial strategies and potentially positive changes to the company's financial management.
The appointment of a new CFO is often seen as a significant event for a company, as it can lead to changes in financial strategy and management. Investors may view this change positively if they believe Scott Leffler can contribute to the company's growth and financial health. The transition period with Bryan Riggsbee as an advisor suggests a well-planned handover, which could reassure investors and minimize uncertainty.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100